1
However, the optimal strategy and target level for lipid reduction remain uncertain.
2
Char length, weight, age, condition factor and lipid content explained additional variance.
3
A new method to measure the activity of lipid-metabolizing enzymes is described.
4
Collectively, emerging data support an essential role of glucagon for lipid metabolism.
5
Conclusions: The results suggest an inverse relationship between lipid levels and AF.
6
Objective: Statins have pleiotropic effects that are independent of their lipid-lowering ability.
7
Conclusions: VSG reduced postprandial levels of plasma lipid, independently of body weight.
8
However, the molecular links between lipid metabolism and IL-1β production remain obscure.
9
They should also bring up any family history related to lipid disorders.
10
The SNHG16 silencing particularly affected expression of genes involved in lipid metabolism.
11
Conclusions: Associations of genetic variants with lipid levels over time are complex.
12
In all groups lipid parameters were within accepted guidelines for cardiovascular risk.
13
This effect is suggested to be mainly due to the lipid-lowering effect.
14
Different adipose depots respond differently to an increased demand for lipid storage.
15
Moreover, intact mitochondria and lipid peroxidation were investigated using a model system.
16
Glomerular lipid deposition and glomerulosclerosis were observed at 18 months of age.
